… , redox signaling targeting as anticancer therapy, introduces using agents to inactivate
various redox regulatory … Application of miRNA as targeting therapy has also been explained. …

… for anticancer therapy involving redox-activated prodrug strategies and redox modulation. …
Here we describe the potential role of redox modulation in the mechanism of action of metal …

… ROSelevating and ROS-depleting anticancer strategies and their mechanisms are … therapy
choice depends on a complete understanding of cancer cell redox state, namely, the “redox …

… In this article we review anticancer drugs currently in development that target cellular … In
this article, the role of redox regulation in carcinogenesis and its potential as a therapeutic target …

… These are the reasons MTHFD2 may symbolize a likely mitochondrial redox anticancer
therapeutic agent. In a murine model of AML, blocking MTHFD2 by silencing with shRNA the …

… Recently, anticancer therapies that induce … redox homeostasis and causes severe damage
in cancer cells. In this review, we describe ROS-inducing cancer therapy and the anticancer …

… that increased oxidative stress by exogenous ROS generation therapy has an effect on
selectively killing … of redox regulation in CSCs and the pivotal role of ROS in anticancer treatment. …

… published every year on the anticancer activity of transition metal complexes, in … redox
processes in cancer metabolic pathways, and how tumor development may be hindered by redox …

… to enhance the ROS regulation efficient. Finally, we illustrate the prospects of the redox
regulating nanotechnology, including combined/synergistic anticancer therapies and challenges …

… intracellular redox status and … Therapeutic inhibition of the OPP and/or the GSH defense
system might increase the sensitivity of gastric and colon cancer cells to anti-cancer therapy.…